chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Very heavy menstration, lasting more than one week, soaking a pad an hour, heaviest period I have ever experienced in my life, no pain just very heavy flow
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On an unknown date in 2008, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX did not prevent shingles, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 18-NOV-2015, the patient was treated at a pain center for the onset of a severe vesicular rash, which was diagnosed as herpes zoster. The patient was prescribed NORCO and tramadol for management of her painful symptoms. On or about 06-JAN-2016, the patient sought subsequent treatment for a persistent vesicular rash, which was diagnosed as post-herpetic neuralgia. The patient was prescribed LYRICA, NORCO, tramadol, and prednisone for management of her painful symptoms and chronic pain. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Intusussception.  Per report was reduced by air contrast enema (but I did not speak to provider directly)
AFTER COVID19 VACCINATION, PATIENT EXPERIENCED NUMBNESS, TINGLING, DIZZINESS, WEAKNESS, LIGHTHEADEDNESS AND DIAPHORESIS AT FOREHEAD. NO LOC, NO DIB, NO SYNCOPE, NO CHEST PAIN. AFTER 15 MINUTES PATIENT WAS ASYMPTOMATIC. LEFT WITH FATHER TO HOME AT 11:16 AM.  VITAL SIGNS:  1100 BP 72/36, HR 88, RR 20 1105 BP 86/46, HR 84, RR 20 1110 BP 88/62, HR 82, RR 20 1115 BP 96/68, HR 80, RR 20 1116 BP 102/70, HR 82, RR 20
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  ACUTE NON ST ELEVATION MI LEFT FACIAL MUSCLE WEAKNESS
Vaccine admin 0n )1/06/21  Very mild local reaction.  2 weeks later and 6 weeks later injection site became red, swollen, itchy and painful--resolved after 24 hours    On  05/10/21 injection site became very red and swollen and painful  did not resolve  became worse and was diagnosed as shingles on 05/12 diagnosed as shingles  cond improving except for pain and itching at injection site 06/28/21
This spontaneous report as received from a health care worker refers to a patient of unknown age and gender. No information about medical history, concurrent conditions were reported for the patient. On 13-MAR-2015 the patient was vaccinated with MMR II lot # H017435, 0.5 ml, subcutaneously that expired on 20-SEP-2014. The reporter stated that dose was supported by the patient. No adverse experience reported. The outcome of events reported is unknown. No product quality complaint was involved. Additional information has been requested.
Severe angioedema (facial swelling) treated unsuccessfully with Benadryl. Swelling went down over time (48 hours). The patient had repeated angioedema/urticaria/unexplained bruising for five months. Consultations and testing with an allergist, hematologist, and dermatologist never resulted in any diagnosis.
Suffering long term side effects from the Moderna COVID-19 infection/Side effects are getting more severe and are not going away; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Suffering long term side effects from the Moderna COVID-19 infection/Side effects are getting more severe and are not going away) in a male patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Suffering long term side effects from the Moderna COVID-19 infection/Side effects are getting more severe and are not going away). At the time of the report, VACCINATION COMPLICATION (Suffering long term side effects from the Moderna COVID-19 infection/Side effects are getting more severe and are not going away) had not resolved.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       No concomitant medications were reported.  Treatment information was not provided.  The reporter had a friend who was suffering long term side effects from the Moderna COVID-19 infection. It was reported that her friend is a male who was suffering several of the listed side effects to the Moderna COVID-19 vaccine that one can find in the patient information. The reporter stated that the side effects were getting more severe and it was not going away.   Reporter did not allow further contact
In her spouse present, prior to receiving her vaccinations, patient stated that she wasn't good with needle. While receiving the doses, patient breathed in and out very fast to overcome the pain and the fear of needle. As soon as patient received both vaccinations, patient stated that she felt pain on injections sites. She doesn't feel right.  She sat for a little, may be 5 minutes, she started to feel nauseated, ear ringing, seeing spots around the room. She fainted and came out of it on her own. She stated that she felt warm and chill at the same time, with visible perspirations. We sat with her for another 20-30 minutes. She felt better, was able to hold conversation.  I confirmed that she was able to stand up and take steps without assistance prior to leaving the consultation room
Rash on right side of torso in two areas.  Dr. treated symptoms that were resolved within 9 days.
stomach ache/terrible stomach ache; pain; This is a spontaneous report from a contactable consumer (patient's husband). This is report 4 of 4 for the reporter's wife. A 68-year-old female patient (wife) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: EN6201, Expiry Date: 30Jun2021), via an unspecified route of administration in left upper arm on 16Feb2021 at 3:45PM as single dose for COVID-19 immunization. Medical history included immune deficient and has additional issues and spinal surgical pain. Concomitant medication included oxycodone (XTAMPZA ER) at 18mg for spinal surgical pain. No additional vaccines administered on the same date of the Pfizer suspect. No prior vaccinations within 4 weeks. She does not get a lot of vaccines and this is something he has to get on her about. Reporter was concerned about his wife getting the second dose of the COVID Vaccine. She was due to get second shot on 09Mar2021. She was adamant about getting it. He was worried because she has more health issues. 24 hours later she got a terrible stomachache and pain which started in the afternoon of 18Feb2021. It lasted 3-4 days almost five days before it went away. The pain is gone now. It was low abdominal pain. It went away on 22Feb2021 (today as reported). His wife does not want to ask about her getting the 2nd dose. She would rather go in blind and not know anything. A visit to emergency room and physician's office was not required for events. The outcome of events was recovered on 22Feb2021.  No follow-up attempts are possible. No further information is expected.
Tightness in throat and phglem. Onset approx 20 minutes after vaccination. Took 2 benadryls approx 1 hour after vaccination. Symptoms gradually improved over the next few hours. I was able to swallow and did not seem to have any trouble breathing but took two puffs of albuterol  approx 2 hours after vaccination as a precautionary measure. Also used Nasalcrom about one hour after vaccination.  At approx 4 hours after vaccination, symptoms mostly appear to be resolving so I am checking "YES" for ITEM 20.
GAVE IMMUNIZATIONS TO A 6 MONTH OLD INFANT. INFANT HAD RECEIVED THE SAME IMMUNIZATION ON 05/01/2008 BUT A DIFFERENT LOT NUMBER. MOTHER AND FATHER NOTED THAT AROUND THE RT UPPER LEG WHERE THE PNEUMOCOCCAL CONJUGATE VACCINE 7-VALENT, PREVNAR A RED AREA WAS DEVELOPING THAT WAS IRREGULAR IN SIZE AND SLIGHTLY ELEVATED ABOUTN 4 INCHES BY 2 INCHES. THE AREA WAS ALSO SLIGHTLY SWOLLEN. THIS WAS NOTED 10 MINUTES AFTER THE INJECTION WAS GIVEN. THE SITE WAS WATCHED FOR INCREASING SEVERITY BUT DID NOT WORSEN WHILE THE FAMILY WAS AT THE CLINIC. THE FAMILY WAS ADVISED TO NOTIFY CLINIC IF THE SITE WORSENS AND TAKE INFANT TO PRIMARY CARE DOCTOR IF SITE WORSENS AND CHILD BECOMES IRRITABLE OR CHANGE IN MENTAL STATUS DEVELOPS. THE MOTHER STATES IT WAS NOT GETTING WORSE AND THE FAMILY LEFT THE CLINIC.
Received immunization 01/03/2019 at approx. 4pm. No problems experienced until awoke Saturday 01/05/2019 with 6 in diameter redness, firm and hot to touch. No fever or other problems noted. Went to Urgent Care, physician stated it was a reaction to immunization and an antibiotic (does not know name) X 7 days, and BENADRYL po. Started to look better on Monday 01/09/2019.
4-6 vesicular papular lesions  one on scalp, few on trunk started 2 wks after vaccine.
Fatigue; Headache; Fever 100.2F; Nausea; Stomachache; Abdominal pain; Cramps on arm, leg and back left side; Running nose; Sore throat; Thirsty; Finger ache, like arthritis symptoms mostly left side.; Body ache; This is a spontaneous report from a non-contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the arm left on 19Apr2021 at 13:00(at the age of 45-years-old) as a single dose for COVID-19 immunisation. The medical history included asthma and allergy to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications were not reported. On 19Apr2021 at 19:30, the patient experienced fatigue, headache, fever 100.2 F, nausea, stomachache, abdominal pain close to ovaries location, cramps on arm, leg and back left side, running nose, sore throat, thirsty, finger ache like arthritis symptoms mostly left side and body ache. On 19Apr2021, the patient underwent body temperature test and the result was found to be 100.2 Fahrenheit. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fatigue, headache, fever 100.2 F, nausea, stomachache, abdominal pain, cramps on arm, leg and back left side, running nose, sore throat, thirsty, finger ache like arthritis and body ache were recovering at the time of this report.    No follow-up attempts are possible. No further information is expected.
BODY ACHES; JOINT PAIN; HEADACHE; LOW GRADE FEVER; FATIGUE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 01-APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On 01-APR-2021, the subject experienced body aches. On 01-APR-2021, the subject experienced joint pain. On 01-APR-2021, the subject experienced headache. On 01-APR-2021, the subject experienced low grade fever. On 01-APR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, joint pain, and low grade fever on 04-APR-2021, and headache, and fatigue on 05-APR-2021. This report was non-serious.
Systemic: Fainting / Unresponsive-Medium, Systemic: Vomiting-Medium, Additional Details: patient fainted for several seconds, when he came to, he was shaky and sweating. then vomited several times. completely recovered
Information has been received from a medical assistant, for GARDASIL, a Pregnancy Registry Product, concerning a 17 year old female who was vaccinated with the first dose of GARDASIL on 02-FEB-2009, the second dose on 04-MAY-2009 IM 0.5 ML right deltoid (lot#: 0151). There was no concomitant medication. On 09-MAY-2009 the patient experienced a warm, swollen and painful injection site reaction and returned to the office on 12-MAY-2009. The patient was instructed to treat the area with cold compresses. On 14-MAY-2009, the patient took a pregnancy test and it was positive. The medical assistant did not have the patient's Last Menstrual Period date or Estimated Delivery Date. Subsequently the patient recovered from the injection site reaction on an unspecified date. The medical assistant did not know the name of the patient's OBGYN physician and no other detail at the time of reporting. Additional information has been requested.
Approximately 2 minutes after the patient received the vaccine, the patient had other questions and while talking about the vaccine, the patient's eyes rolled back and he experienced a vasovagal reaction (syncope). Although he was sitting in a chair, his head fell to the left and his forehead bumped the table. The patient's legs were elevated and his upper body was laid back. Ammonia inhalant was crushed and immediately placed under the patient's nose. The patient came back to consciousness approximately 30 seconds after passing out. Patient was asked what symptoms he felt leading up to passing out. He said that he suddenly felt dizzy and does not remember much after. Patient states that he did not eat breakfast prior to receiving the vaccine and has a history of not doing well with needles or vaccines. He states that he now feels completely fine, however, the patient was advised to stay 30 minutes for monitoring, and once he felt comfortable standing up, a nurse walked with him to the observation area. Patient was provided an ice pack for his forehead. Observation nurse was notified of the adverse event and is now monitoring the patient.
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 74-year-old female patient. No information was provided regarding medical history, concurrent conditions, or concomitant medications.  On an unknown date in 2009, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route of administration were not specified) for the long-term prevention of shingles and zoster-related conditions. On an unspecified date, the patient experienced shingles. On an unspecified date, the patient was treated by a healthcare provider for shingles.  The outcome of the event shingles was not reported. The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).
his bottom lip started to swell up very bad; This is a spontaneous report received from a contactable consumer(patient). A 22-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose via an unspecified route of administration, administered in left arm at the age of 22-year-old on 28May2021 17:30 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. Medical history was none. There was no known allergies. The patient's concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hadn't been tested for COVID-19. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. About two days (30May2021 12:00) after the vaccine dose his bottom lip started to swell up very bad. The swelling went down after using ice and he was currently monitoring if any additional swelling occurs in his lips and throat area.  Treatment received for the event included diphenhydramine hydrochloride (Benadryl). The adverse event resulted in doctor or other healthcare professional office/clinic visit. The outcome of the event was recovering.  Information on the lot/batch number has been requested.
Fever up to 102 on day of inject; Liquid APAP given & fever gone next AM; High pitched cry-restless all night;
Received #2 TWINRIX on 1/10/2005. 2 days later developed nausea , warm and cold spells , generalized body itching. Episodes last 2 hours and recur every 4 days.
Mild headache, body aches and seizure. Resident has a history of seizures  EMS was contacted and resident was administered Gabapentin and Tylenol. Resident is fully recovered
Vaccine leaked out of the deltoid muscle; A spontaneous report was received from a healthcare professional concerning a 49-year-old, male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and vaccine leaked out of the deltoid muscle.  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.   On 05 Jan 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: 039K20A) intramuscularly for prophylaxis of COVID-19 infection.   On 05 Jan 2021, the patient received the mRNA-1273 vaccine using a one inch needle. Right after administration, the vaccine leaked out of the deltoid muscle of the patient's arm. The patient's vaccinator thought the patient received half the dose. Treatment information was not provided.   Action taken with mRNA-1273 in response to the event was not provided.   The event, vaccine leaked out of the deltoid muscle, was considered resolved on 05 Jan 2021.; Reporter's Comments: This report refers to a case of incorrect dose administered for mRNA-1273, lot # 039K20A. There were no reported AEs associated with this case of incorrect dose administered.
After injection, practitioner noted the vaccine had expired 05/31/2023.  On 11-3-23 patient noted that the injection site was erythematous, raised and warm to the touch.  No further signs/symptoms reported.
Patient reported she was 9&1/2 weeks pregnant at time of vaccine and when she had her 12 week check-up she was told her pregnancy had terminated.  She then required in induced miscarriage approximately two weeks later.
Swelling in L thigh 8 1/2x12cm induration at 48 hours-inconsolable crying x 12hrs, afebrile with max induration. Medial at sore of DTaP.
Patient reports pins and needles tingling sensation in left arm and leg, as well as left side of mouth. She also reports dizziness. Benadryl was administered per MD order. Patient was monitored and recovered. Stable for discharge.
Started with itching at site R thigh, red and swollen next day, worse on 3rd day. Patient seen in urgent care 3/22/07. 14x12cm induration with erythema to Right thigh. No other symptoms.
This spontaneous report was received from a Licensed Practical Nurse and refers to an unspecified number of patients of unknown age and gender. No information regarding the patient's medical history, concurrent conditions and concomitant medications was provided. On unspecified dates, the patients were vaccinated with improperly stored doses of VAQTA (lot # L036300, expiration date: 04-NOV-2016, dose, route of administration and injection site were not reported). No adverse effects were reported. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
Red ring around area where vaccine was given approximately 7cm x 7cm. Skin is hot to touch, swollen, itchy, nerve pain up and down shoulder and arm.
Headache lightheadedness, headache daily or every few days, lasting until mid-March Narrative:  Other Relevant History:
Five minutes after vaccination the patient passed out. She lost consciousness for less than one minute. She continued breathing the entire time. The pharmacist guided her to lay on the floor and elevated her feet. After a couple of minutes the patient felt good enough to sit up and start talking. She was offered a sugary beverage to sip on. EMTs responded and checked the patient's blood sugar which was 104.  After 30 minutes the patient was able to walk out to her vehicles where a family member took her home to rest.
I had an onset of Vertigo. I was so dizzy I was unable to walk. I was vomiting due to the spinning and dizziness experienced. I had to go to the ER to receive fluids due to the vomiting. This lasted for  three days. I am still dizzy but it is manageable.
Onset of a rash on his hands, and tops of feet 10 days post vaccination with SPV and AVA on 21 Mar 14. Rash initially started on wrists, spread to fingers and feet and now has a lesion on his left elbow. Stated lesions are itchy, denies pain but notes a "tight feeling" along his fingers. He denies lesions in his mouth/lips, and other parts of his body. He denies headache, fever, N/V, chest pain, or shortness of breath. He denied problems with his vaccination site. Other than rash reports he is doing well. Multiple macules and papules noted on palmar and dorsal surfaces of hands, between fingers and one lesion on elbows for total of 10-15 lesions. No pustules or vesicles. Slight excoriation of wrist lesion.
Continuing Irregular and fast heartbeat with high blood pressure.  20 days non stop so far.
Information has been received from a health professional concerning a 63 year old white female patient who on approximately 12-JUL-2006 was vaccinated with a dose of Pneumovax 23 (lot# 651321/1036P). There was no illness at the time of vaccination. On 12-JUL-2006, twelve hours after vaccination, the patient experienced erythema, and a painful, tender, swollen upper arm. Unspecified medical attention was sought. It was noted that the pain and swelling responded to heat. The patient was also treated with oral steroids and antibiotics. No diagnostic laboratory studies were performed. At the time of this report, the patient was recovering from pain and swelling and the outcome of erythema and tenderness was unknown. The physician requested a lot check. No product quality complaint was involved. The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory. The lot complies with the standards of the Center for Biologics Evaluation and Research and was released. Additional information has been requested.
Within 5 minutes of receiving the vaccine, patient developed tingling and warmth in her chest and she felt like her heart rate was increasing.  She also felt short of breath.  She stated she had no difficulty swallowing but that she felt like the sensation in her chest was moving towards her throat.  She states this felt similar to the reaction she had after a bee sting.  Patient was given a dose of IM epinephrine and was advised to go to the ED.  At the ED she was given IV methylprednisolone 125 mg, IV diphenhydramine 50 mg and IV famotidine 20 mg.  Patient's symptoms resolved and she was observed for 3 hours with no return of symptoms and was released.
This spontaneous report was received from a registered nurse concerning a patient of an unknown age and gender. Concurrent conditions, medical history and allergies were not reported. On 09-AUG-2014, the patient received VARIVAX (Merck) lot number J014400, expiration date: 13-NOV-2015 (dose and route were not provided), which was improperly stored on 05-AUG-2014 at 11:18 am for 3 hours 10 minutes. Other suspect and concomitant therapies were not reported. No adverse symptoms were reported. The temperature excursion for the VARIVAX (Merck) was supported with in-house stability data. This is one of several reports received from the same reporter. Additional information has been requested.
Pain and weakness in right leg. Weakness worsens with use up to the point where leg feels like jelly. Treatment with ice packs. Symptoms persist/ have not been resolved